Alkhasawneh et al., in 2019, reported the case of a 52-year-old woman, previously operated on for breast cancer and previous melanoma resulting in pT1b, who presented with a chest lesion that had entirely lost all melanocytic immunohistochemical markers, and expressed (aberrantly) only GATA-3. This evidence concerns the gene GATA3 and breast cancer.